Pure Global

A Study of Sex Differences in Neurocirculatory Control - Trial NCT06261034

Access comprehensive clinical trial information for NCT06261034 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06261034
Not yet recruiting
Trial Details
ClinicalTrials.gov • NCT06261034
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study of Sex Differences in Neurocirculatory Control
Sex Differences in Neurocirculatory Control With Obstructive Sleep Apnea

Study Focus

Obstructive Sleep Apnea

Observational

Sponsor & Location

Mayo Clinic

Rochester, United States of America

Timeline & Enrollment

N/A

Mar 01, 2024

Mar 01, 2027

60 participants

Primary Outcome

Blood pressure,Arterial stiffness,Endothelial function

Summary

The purpose of this study is to investigate potential sex differences in neurocirculatory
 control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

ICD-10 Classifications

Sleep apnoea
Sleep disorders
Sleep disorder, unspecified
Primary sleep apnoea of newborn
Nonorganic sleep disorders

Data Source

ClinicalTrials.gov

NCT06261034

Non-Device Trial